Evolving Care with COVID-19 for T2D Patients
In response to the COVID-19 pandemic, Centers for Medicare and Medicaid Services (CMS) has broadened access to Medicare telehealth services so that beneficiaries can receive a wider range of health care services while at home¹. Listen to Dr. Jay Shubrook, DO, a primary care physician, and Dr. Bankim Bhatt, MD, an adult endocrinologist discuss diabetes management, telemedicine, and lessons learned in the time of COVID-19.
2020 Episode 7 – Evolving Care with COVID-19 for T2D Patients: Management, Telemedicine, and Lessons Learned
Jay Shubrook, DO, FAAFP, FACOCP is a Family Physician and Fellowship trained Diabetologist. He is currently a Professor at Touro University California. Dr. Shubrook’s professional work and passion focuses on preparing the primary care workforce to better manage diabetes; And optimizing the prevention and treatment of diabetes. He served as the Director of an integrated comprehensive diabetes care center and also as the Director of Clinical Research at both Ohio University Heritage College of Osteopathic Medicine (HCOM) and more recently Touro University California College of Osteopathic Medicine; and is the immediate past Chair of the Primary Care Advisory Board of the American Diabetes Association.
Bankim A. Bhatt, MD is the Department Chief for St. Luke’s Center for Diabetes & Endocrinology as well as the Clinical Associate Professor of Medicine at St. Luke’s/Temple University of Medicine. Dr. Bhatt is an adult endocrinologist and is board-certified in Internal Medicine and Endocrinology and Metabolism. He is also a Fellow of the American College of Endocrinology, the American College of Physicians, and a member of the Endocrine Society and the American Diabetes Association where he has presented his research findings. His research has also been published in leading medical journals.